KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accuray (ARAY) Deferred Taxes (2023 - 2026)

Accuray posted quarterly Deferred Taxes of $36000.0 for Q1 2026, down 66.04% year-on-year from $106000.0 in Q1 2025, and up 24.14% on a QoQ basis from $29000.0 in Q4 2025.

Accuray (ARAY) has 4 years of Deferred Taxes data on file, last reported at $36000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Deferred Taxes fell 66.04% year-over-year to $36000.0; the trailing twelve-month figure through Mar 2026 stood at $165000.0 (down 85.48% YoY), and the FY2025 full-year result was $156000.0, down 88.87% from the prior year.
  • Deferred Taxes for Q1 2026 stood at $36000.0, up from $29000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $939000.0 in Q1 2024 and bottomed at -$75000.0 in Q3 2024.
  • The 4-year median for Deferred Taxes is $106000.0 (2025), against an average of $232111.1.
  • The widest annual swing landed in 2024, when Deferred Taxes sank 111.72%; it then surged 92.0% in 2025.
  • A 4-year view of Deferred Taxes shows it stood at $254000.0 in 2023, then slumped by 34.65% to $166000.0 in 2024, then plunged by 82.53% to $29000.0 in 2025, then increased by 24.14% to $36000.0 in 2026.
  • The last three Deferred Taxes figures came in at $36000.0 (Q1 2026), $29000.0 (Q4 2025), and -$6000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -33.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -16.70 Mn
10 Accuray 47,295.88 -38.49 Mn 25.29 Mn 36,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 36,000.00
Dec 31, 2025 29,000.00
Sep 30, 2025 -6,000.00
Mar 31, 2025 106,000.00
Dec 31, 2024 166,000.00
Sep 30, 2024 -75,000.00
Mar 31, 2024 939,000.00
Dec 31, 2023 254,000.00
Sep 30, 2023 640,000.00